Skip to main content

Table 1 Characteristics of patients with Behçet’s disease in the RISE registry

From: Epidemiology and treatment of Behçet’s disease in the USA: insights from the Rheumatology Informatics System for Effectiveness (RISE) Registry with a comparison with other published cohorts from endemic regions

Characteristics

Total patients (N = 1323)

Age, mean (SD)

48.7 (16.3)

Sex (female), N (%)

1049 (79.3)

Race, N (%)

White

882 (66.7)

Hispanic or Latino

72 (5.4)

Black or African American

65 (4.9)

Asian

34 (2.6)

Othera

106 (11.9)

Missing

164 (12.4)

Insurance, N (%)

Medicare

205 (15.5)

Private

557 (42.1)

Medicaid

43 (3.2)

Otherb

75 (5.7)

Missing

443 (33.5)

U.S. geographic division, N (%)

East North Central

22 (1.7)

West North Central

153 (11.6)

Mid-Atlantic

159 (12.0)

Mountain

109 (8.2)

New England

396 (29.9)

Pacific

116 (8.8)

South Atlantic

153 (11.6)

East South Central

62 (4.7)

West South Central

144 (10.9)

Missing

< 10

Comorbidities, N (%)

Osteoporosis

155 (11.7)

Hypertension

117 (8.8)

Hyperlipidemia

62 (4.7)

Cerebrovascular accidents /TIA

51 (3.7)

Diabetes mellitus

48 (3.6)

Charlson comorbidity index score, mean (SD)

0.55 (1.0)

Charlson comorbidity index score

 1

339 (25.6)

 ≥ 2

123 (9.3)

Clinical characteristics

Number of visits in RISE, median (IQR)

4.5 (2.5, 8)

Duration of follow-up time (years), median (IQR)

2.5 (0.9, 4.4)

  1. RISE Rheumatology Informatics System for Effectiveness, TIA transient ischemic attack, IQR interquartile range
  2. aOther race: Not determined OMB race, and American Indian or Alaska, Native Hawaiian
  3. bOther insurance: include Veteran